Compare Rubicon Organics, Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 33 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.06
-32.52%
0.72
Revenue and Profits:
Net Sales:
15 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.0%
0%
-11.0%
6 Months
4.71%
0%
4.71%
1 Year
17.11%
0%
17.11%
2 Years
-3.26%
0%
-3.26%
3 Years
-47.65%
0%
-47.65%
4 Years
-71.1%
0%
-71.1%
5 Years
-86.09%
0%
-86.09%
Rubicon Organics, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
65.47%
EBIT Growth (5y)
4.41%
EBIT to Interest (avg)
-14.91
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.96
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
2.76%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.73
EV to EBIT
-1.93
EV to EBITDA
-2.57
EV to Capital Employed
0.68
EV to Sales
0.46
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-35.38%
ROE (Latest)
-33.51%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (2.76%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
15.00
12.40
20.97%
Operating Profit (PBDIT) excl Other Income
-2.50
-2.60
3.85%
Interest
0.20
0.20
Exceptional Items
4.40
3.30
33.33%
Consolidate Net Profit
0.80
-0.30
366.67%
Operating Profit Margin (Excl OI)
-225.70%
-274.10%
4.84%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 20.97% vs -12.68% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 366.67% vs 0.00% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
48.70
40.10
21.45%
Operating Profit (PBDIT) excl Other Income
-11.00
-9.30
-18.28%
Interest
1.10
1.10
Exceptional Items
13.60
11.30
20.35%
Consolidate Net Profit
-2.60
-1.80
-44.44%
Operating Profit Margin (Excl OI)
-293.50%
-308.60%
1.51%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 21.45% vs 12.96% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -44.44% vs 53.85% in Dec 2023
About Rubicon Organics, Inc. 
Rubicon Organics, Inc.
Pharmaceuticals & Biotechnology
Rubicon Organics Inc is a Canada-based company engaged in cannabis business sector. The Company is a organic cannabis company with operations in Canada, California and Washington. The Company, through its subsidiary Vintages Organic Cannabis Company Inc, is a late-stage applicant under Health Canada's Access to Cannabis for Medical Purposes Regulations (ACMPR).
Company Coordinates 
Company Details
505 - 744 West Hastings Street , VANCOUVER BC : V6C 1A5
Registrar Details






